Researchers examined the addition of 3D total-body photography and sequential digital dermoscopy imaging to usual care on outcomes in patients at high risk for melanoma.

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she ...

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

From using infants gut bacteria to protect adults from cancer, to growing rice on the ocean's surface and non-browning ...

Regeneron Pharmaceuticals Inc.'s victory against Amgen Inc. over anticompetitive drug bundling reinforces the necessity for ...

Awarded earlier this year, the $44M Birmingham Biotechnology Hub grant was set to support the growth of Alabama's ...

Fieldstone Bio recently raised $5 million in seed funding led by Ubiquity Ventures with participation from E14 and LDV ...

Texas Gov. Greg Abbott announced that NtxBio, a New Mexico health care biomanufacturing company, is building a new facility ...

While addressing the Cabinet Briefing, Information and Broadcasting Minister Ashwini Vaishnaw highlighted how Science & ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

Excessively long approval timelines and outdated regulations designed for chemicals are harming Europe’s competitive edge in ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...